6617 Phase II study of NGR-hTNF, a selective vascular targeting agent (VTA), in previously treated patients (pts) with advanced hepatocellular carcinoma (HCC) A. Santoro,G. Citterio,T. Pressiani,V. Gregorc, L. Rimassa,F. G. De Braud, G. Rossoni,F. Caligaris Cappio,A. Lambiase,C. BordignonEJC SUPPLEMENTS（2009）引用 1|浏览15暂无评分关键词phase ii studyAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
